Eledon Pharmaceuticals (ELDN) Enterprise Value Growth (5y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Eledon Pharmaceuticals | 419.90 Mn | 203.87 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -88.00% |
| Dec 31, 2025 | -70.70% |
| Sep 30, 2025 | -78.52% |
| Jun 30, 2025 | -65.12% |
| Mar 31, 2025 | -70.12% |
| Dec 31, 2024 | -73.99% |
| Sep 30, 2024 | -48.54% |
| Jun 30, 2024 | -43.58% |
| Mar 31, 2024 | -42.35% |
| Dec 31, 2023 | -31.55% |
| Sep 30, 2023 | -47.90% |
| Jun 30, 2023 | -39.63% |
| Mar 31, 2023 | 16.03% |
| Dec 31, 2022 | -26.56% |
| Sep 30, 2022 | 13.65% |
| Jun 30, 2022 | 16.45% |
| Mar 31, 2022 | -25.73% |
| Dec 31, 2021 | -137.15% |
| Sep 30, 2021 | -38.24% |
| Jun 30, 2021 | 5.42% |
| Mar 31, 2021 | 8.45% |
| Dec 31, 2020 | 17.47% |
| Sep 30, 2020 | 21.16% |
| Jun 30, 2020 | 31.73% |
| Mar 31, 2020 | 37.80% |
| Dec 31, 2019 | 39.14% |
| Sep 30, 2019 | 36.59% |
| Jun 30, 2019 | 8.31% |
| Mar 31, 2019 | 12.69% |
| Dec 31, 2018 | 16.39% |
| Sep 30, 2018 | 6.72% |